Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS 3
NCT00975897Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Jul 2009
- Primary completion
- Aug 2010
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cetuximab, bevacizumab, oxaliplatin, irinotecan in colorectal cancer (CRC), sponsored by Medical Research Council. Started Jul 2009; status: completed.
02
Drugs
cetuximabbevacizumaboxaliplatinirinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00975897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975897.